Table 2.
Thin-filament-based intensity reflections
Group | SL (μm) | Condition | Second ALL | Sixth ALL | Seventh ALL |
---|---|---|---|---|---|
Control | 2.70 | Preactivation | 0.047 ± 0.007 | 1 | 0.323 ± 0.015 |
Activation | 0.186 ± 0.009* | 1.120 ± 0.028* | 0.392 ± 0.031* | ||
>3.60 | Preactivation | 0.074 ± 0.005 | 1 | 0.252 ± 0.003 | |
Activation | 0.150 ± 0.002* | 0.946 ± 0.006* | 0.236 ± 0.002 | ||
Patient | 2.70 | Preactivation | 0.033 ± 0.007 | 1 | 0.403 ± 0.015 |
Activation | 0.118 ± 0.008*,# | 1.019 ± 0.012# | 0.407 ± 0.013 | ||
>3.60 | Preactivation | 0.043 ± 0.010 | 1 | 0.359 ± 0.011 | |
Activation | 0.129 ± 0.007* | 1.004 ± 0.020 | 0.357 ± 0.016 |
Values are normalized to total intensity of sixth ALL in absence of calcium. All values are means ± se. SL, sarcomere length.
P <0.05 vs. preactivation for same group (control or patient).
P <0.05 vs. control for same condition (preactivation or activation).